Evercore ISI Assumes Travere Therapeutics (TVTX) at Outperform
Tweet
Share
E-mailGet Alerts TVTX Hot Sheet
Price: $62.14 +1.16%
Rating Summary:
12 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Rating Summary:
12 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 13 | Down: 14 | New: 11
Join SI Premium – FREE
Evercore ISI analyst Gavin Clark-Gartner assumes coverage on Travere Therapeutics (NASDAQ: TVTX) with a Outperform rating and a price target of $45.00.
For an analyst ratings summary and ratings history on Travere Therapeutics click here. For more ratings news on Travere Therapeutics click here.
Shares of Travere Therapeutics closed at $17.92 yesterday.
You May Also Be Interested In
- Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
- Leerink Starts Freenome Inc. (FRNM) at Outperform
- RBC Capital Starts Krystal Biotech (KRYS) at Outperform
Create E-mail Alert Related Categories
New CoverageSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
